tetano
Editor, Senior Moderator
Int J Infect Dis. 2019 Sep 4. pii: S1201-9712(19)30355-8. doi: 10.1016/j.ijid.2019.08.029. [Epub ahead of print]
[h=1]High performance of rapid influenza diagnostic test and variable effectiveness of influenza vaccines in Mexico.[/h] Castillejos M[SUP]1[/SUP], Cabello-Guti?rrez C[SUP]2[/SUP], Chore?o-Parra JA[SUP]3[/SUP], Hern?ndez V[SUP]2[/SUP], Romo J[SUP]1[/SUP], Hern?ndez-S?nchez F[SUP]2[/SUP], Mart?nez D[SUP]1[/SUP], Hern?ndez A[SUP]1[/SUP], Jim?nez-?lvarez L[SUP]4[/SUP], Hern?ndez-Cardenas CM[SUP]5[/SUP], Becerril-Vargas E[SUP]1[/SUP], Mart?nez-Orozco JA[SUP]1[/SUP], Sandoval-Guti?rrez JL[SUP]1[/SUP], Guadarrama C[SUP]1[/SUP], Olvera-Masetto E[SUP]1[/SUP], Alfaro-Ramos L[SUP]1[/SUP], Cruz-Lagunas A[SUP]4[/SUP], Ram?rez G[SUP]4[/SUP], M?rquez E[SUP]4[/SUP], Pimentel L[SUP]6[/SUP], Regino-Zamarripa NE[SUP]7[/SUP], Mendoza-Milla C[SUP]4[/SUP], Goodina A[SUP]6[/SUP], Hern?ndez-Montiel E[SUP]6[/SUP], Barquera R[SUP]8[/SUP], Santiba?ez A[SUP]9[/SUP], Dom?nguez-Cherit G[SUP]10[/SUP], P?rez-Padilla R[SUP]1[/SUP], Regalado J[SUP]11[/SUP], Santill?n-Doherty P[SUP]11[/SUP], Salas-Hern?ndez J[SUP]12[/SUP], Z??iga J[SUP]13[/SUP].
[h=3]Author information[/h] 1 Institutional Influenza Committee, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico. 2 Department of Research in Virology and Mycology, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico. 3 Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Escuela Nacional de Ciencias Biol?gicas, Instituto Polit?cnico Nacional, Mexico City, Mexico. 4 Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico. 5 Institutional Influenza Committee, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico. 6 Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico. 7 Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Escuela Nacional de Ciencias Biol?gicas, Instituto Polit?cnico Nacional, Mexico City, Mexico; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico. 8 Laboratory of Archeogenomics, Max Planck Institute, Gena, Germany. 9 Escuela Nacional de Ciencias Biol?gicas, Instituto Polit?cnico Nacional, Mexico City, Mexico; Laboratory of Archeogenomics, Max Planck Institute, Gena, Germany. 10 Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico; Critical Care Unit, Instituto Nacional de Ciencias M?dicas y Nutrici?n Salvador Zubir?n, Mexico City, Mexico. 11 Institutional Influenza Committee, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Direcci?n M?dica, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico. 12 Institutional Influenza Committee, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Direcci?n General, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico. Electronic address: jorgesalash@yahoo.com. 13 Institutional Influenza Committee, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico. Electronic address: joazu@yahoo.com.
[h=3]Abstract[/h] [h=4]OBJECTIVES:[/h] To evaluate the performance of a rapid influenza diagnostic tests (RIDT) and influenza vaccines' effectiveness (VE) during an outbreak setting.
[h=4]METHODS:[/h] We compared the performance of a RIDT with RT-PCR for influenza virus detection in influenza-like illness (ILI) patients enrolled during the 2016/17 season in Mexico City. Using the test-negative design, we estimated influenza VE in all participants and stratified by age, virus subtype, and vaccine type (trivalent vs quadrivalent inactivated vaccines). The protective value of some clinical variables was evaluated by regression analyses.
[h=4]RESULTS:[/h] We enrolled 592 patients. RT-PCR detected 93 cases of influenza A(H1N1)pdm09, 55 of AH3N2, 141 of B, and 13 A/B virus infections. RIDT showed 90.7% sensitivity and 95.7% specificity for influenza A virus detection, and 91.5% sensitivity and 95.3% specificity for influenza B virus detection. Overall VE was 33.2% (95% CI: 3.0 - 54.0; p = 0.02) against any laboratory-confirmed influenza infection. VE estimates against influenza B were higher for the quadrivalent vaccine. Immunization and occupational exposure were protective factors against influenza.
[h=4]CONCLUSIONS:[/h] The RIDT was useful to detect influenza cases during an outbreak setting. Effectiveness of 2016/17 influenza vaccines administered in Mexico was low but significant. Our data should be considered for future local epidemiological policies.
Copyright ? 2019. Published by Elsevier Ltd.
[h=4]KEYWORDS:[/h] Influenza vaccines; Influenza virus infection; Rapid influenza diagnostic test; Vaccine effectiveness
PMID: 31493523 DOI: 10.1016/j.ijid.2019.08.029
Free full text
[h=1]High performance of rapid influenza diagnostic test and variable effectiveness of influenza vaccines in Mexico.[/h] Castillejos M[SUP]1[/SUP], Cabello-Guti?rrez C[SUP]2[/SUP], Chore?o-Parra JA[SUP]3[/SUP], Hern?ndez V[SUP]2[/SUP], Romo J[SUP]1[/SUP], Hern?ndez-S?nchez F[SUP]2[/SUP], Mart?nez D[SUP]1[/SUP], Hern?ndez A[SUP]1[/SUP], Jim?nez-?lvarez L[SUP]4[/SUP], Hern?ndez-Cardenas CM[SUP]5[/SUP], Becerril-Vargas E[SUP]1[/SUP], Mart?nez-Orozco JA[SUP]1[/SUP], Sandoval-Guti?rrez JL[SUP]1[/SUP], Guadarrama C[SUP]1[/SUP], Olvera-Masetto E[SUP]1[/SUP], Alfaro-Ramos L[SUP]1[/SUP], Cruz-Lagunas A[SUP]4[/SUP], Ram?rez G[SUP]4[/SUP], M?rquez E[SUP]4[/SUP], Pimentel L[SUP]6[/SUP], Regino-Zamarripa NE[SUP]7[/SUP], Mendoza-Milla C[SUP]4[/SUP], Goodina A[SUP]6[/SUP], Hern?ndez-Montiel E[SUP]6[/SUP], Barquera R[SUP]8[/SUP], Santiba?ez A[SUP]9[/SUP], Dom?nguez-Cherit G[SUP]10[/SUP], P?rez-Padilla R[SUP]1[/SUP], Regalado J[SUP]11[/SUP], Santill?n-Doherty P[SUP]11[/SUP], Salas-Hern?ndez J[SUP]12[/SUP], Z??iga J[SUP]13[/SUP].
[h=3]Author information[/h] 1 Institutional Influenza Committee, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico. 2 Department of Research in Virology and Mycology, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico. 3 Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Escuela Nacional de Ciencias Biol?gicas, Instituto Polit?cnico Nacional, Mexico City, Mexico. 4 Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico. 5 Institutional Influenza Committee, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico. 6 Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico. 7 Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Escuela Nacional de Ciencias Biol?gicas, Instituto Polit?cnico Nacional, Mexico City, Mexico; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico. 8 Laboratory of Archeogenomics, Max Planck Institute, Gena, Germany. 9 Escuela Nacional de Ciencias Biol?gicas, Instituto Polit?cnico Nacional, Mexico City, Mexico; Laboratory of Archeogenomics, Max Planck Institute, Gena, Germany. 10 Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico; Critical Care Unit, Instituto Nacional de Ciencias M?dicas y Nutrici?n Salvador Zubir?n, Mexico City, Mexico. 11 Institutional Influenza Committee, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Direcci?n M?dica, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico. 12 Institutional Influenza Committee, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Direcci?n General, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico. Electronic address: jorgesalash@yahoo.com. 13 Institutional Influenza Committee, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cos?o Villegas, Mexico City, Mexico; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico. Electronic address: joazu@yahoo.com.
[h=3]Abstract[/h] [h=4]OBJECTIVES:[/h] To evaluate the performance of a rapid influenza diagnostic tests (RIDT) and influenza vaccines' effectiveness (VE) during an outbreak setting.
[h=4]METHODS:[/h] We compared the performance of a RIDT with RT-PCR for influenza virus detection in influenza-like illness (ILI) patients enrolled during the 2016/17 season in Mexico City. Using the test-negative design, we estimated influenza VE in all participants and stratified by age, virus subtype, and vaccine type (trivalent vs quadrivalent inactivated vaccines). The protective value of some clinical variables was evaluated by regression analyses.
[h=4]RESULTS:[/h] We enrolled 592 patients. RT-PCR detected 93 cases of influenza A(H1N1)pdm09, 55 of AH3N2, 141 of B, and 13 A/B virus infections. RIDT showed 90.7% sensitivity and 95.7% specificity for influenza A virus detection, and 91.5% sensitivity and 95.3% specificity for influenza B virus detection. Overall VE was 33.2% (95% CI: 3.0 - 54.0; p = 0.02) against any laboratory-confirmed influenza infection. VE estimates against influenza B were higher for the quadrivalent vaccine. Immunization and occupational exposure were protective factors against influenza.
[h=4]CONCLUSIONS:[/h] The RIDT was useful to detect influenza cases during an outbreak setting. Effectiveness of 2016/17 influenza vaccines administered in Mexico was low but significant. Our data should be considered for future local epidemiological policies.
Copyright ? 2019. Published by Elsevier Ltd.
[h=4]KEYWORDS:[/h] Influenza vaccines; Influenza virus infection; Rapid influenza diagnostic test; Vaccine effectiveness
PMID: 31493523 DOI: 10.1016/j.ijid.2019.08.029
Free full text